Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Silverman

Showing results (621-630 of 756) with videos related to

Pageof 76
Sort By:
Ebiomedicine|June 17, 2026
Effects of sevasemten (EDG-5506) on safety, biomarkers, and functional measures in adults with Becker muscular dystrophy: results of a phase 1b, open-label studyHan Phan, Ben Barthel, Molly Madden, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2018
Identification of cytokine-specific sensory neural signals by decoding murine vagus nerve activityTheodoros P Zanos, Harold A Silverman, Todd Levy, et al.
Journal of Cardiothoracic Surgery|September 6, 2011
Prevalence of dysglycemia among coronary artery bypass surgery patients with no previous diabetic historyJoseph T McGinn, Masood A Shariff, Tariq M Bhat, et al.
Plos One|February 6, 2014
Fluphenazine reduces proteotoxicity in C. elegans and mammalian models of alpha-1-antitrypsin deficiencyJie Li, Stephen C Pak, Linda P O'Reilly, et al.
Muscle & Nerve|June 2, 2025
A Phase 1, Double-Blind, Placebo-Controlled Trial of Sevasemten (EDG-5506), a Selective Modulator of Fast Skeletal Muscle Contraction, in Healthy Volunteers and Adults With Becker Muscular DystrophyJoanne Donovan, Jeffrey A Silverman, Ben Barthel, et al.
American Journal of Medical Genetics|May 16, 2001
An association study of DRD5 with smoking initiation and progression to nicotine dependenceP F Sullivan, M C Neale, M A Silverman, et al.
The Journal of Biological Chemistry|October 18, 2001
SERPINB12 is a novel member of the human ov-serpin family that is widely expressed and inhibits trypsin-like serine proteinasesY S Askew, S C Pak, C J Luke, et al.
Cureus|April 27, 2022
Medical Education Blog and Podcast Utilization During the COVID-19 PandemicPatrick E Boreskie, Teresa M Chan, Chris Novak, et al.
Blood|February 11, 2005
Urokinase-type plasminogen activator is a preferred substrate of the human epithelium serine protease tryptase epsilon/PRSS22Shinsuke Yasuda, Nasa Morokawa, G William Wong, et al.
Human Mutation|March 21, 2020
Functional characterization of four ATP-binding cassette transporter A3 gene (ABCA3) variantsJune Y Hu, Ping Yang, Daniel J Wegner, et al.
Pageof 76

Showing results (621-630 of 756) with videos related to

Sort By:
Pageof 76
Ebiomedicine|June 17, 2026
Effects of sevasemten (EDG-5506) on safety, biomarkers, and functional measures in adults with Becker muscular dystrophy: results of a phase 1b, open-label studyHan Phan, Ben Barthel, Molly Madden, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2018
Identification of cytokine-specific sensory neural signals by decoding murine vagus nerve activityTheodoros P Zanos, Harold A Silverman, Todd Levy, et al.
Journal of Cardiothoracic Surgery|September 6, 2011
Prevalence of dysglycemia among coronary artery bypass surgery patients with no previous diabetic historyJoseph T McGinn, Masood A Shariff, Tariq M Bhat, et al.
Plos One|February 6, 2014
Fluphenazine reduces proteotoxicity in C. elegans and mammalian models of alpha-1-antitrypsin deficiencyJie Li, Stephen C Pak, Linda P O'Reilly, et al.
Muscle & Nerve|June 2, 2025
A Phase 1, Double-Blind, Placebo-Controlled Trial of Sevasemten (EDG-5506), a Selective Modulator of Fast Skeletal Muscle Contraction, in Healthy Volunteers and Adults With Becker Muscular DystrophyJoanne Donovan, Jeffrey A Silverman, Ben Barthel, et al.
American Journal of Medical Genetics|May 16, 2001
An association study of DRD5 with smoking initiation and progression to nicotine dependenceP F Sullivan, M C Neale, M A Silverman, et al.
The Journal of Biological Chemistry|October 18, 2001
SERPINB12 is a novel member of the human ov-serpin family that is widely expressed and inhibits trypsin-like serine proteinasesY S Askew, S C Pak, C J Luke, et al.
Cureus|April 27, 2022
Medical Education Blog and Podcast Utilization During the COVID-19 PandemicPatrick E Boreskie, Teresa M Chan, Chris Novak, et al.
Blood|February 11, 2005
Urokinase-type plasminogen activator is a preferred substrate of the human epithelium serine protease tryptase epsilon/PRSS22Shinsuke Yasuda, Nasa Morokawa, G William Wong, et al.
Human Mutation|March 21, 2020
Functional characterization of four ATP-binding cassette transporter A3 gene (ABCA3) variantsJune Y Hu, Ping Yang, Daniel J Wegner, et al.
Pageof 76